The private obstetrics and gynaecology hospital group's listing on the Hong Kong bourse priced at the very top of the range despite market turbulence.
Dalian Wanda IPO cornerstone investor kicks its holdings into touch with a $369.4 million placement.
The Chinese healthcare leasing business and healthcare service provider prices shares towards the middle of the range amid intensifying Greek drama.
In this Q&A, Standard & Poor's discusses what the default of Kaisa means for bondholders in China generally and what is next for the property developer.
Exchanges are hurriedly refining Stock Connect but investors and bankers urge more reform before the trading link can be easily used as a bridge into mainland China.
PBoC cuts interest rates after Shanghai’s benchmark index flirts with bear market territory. New users of Shanghai-Hong Kong Stock Connect caught in market whiplash.
Mongolia becomes the second non-Chinese sovereign after the UK to issue dim sum bonds as it embarks on a new foreign fundraising programme.
Bank of China traverses the globe with a multi-currency bond in support of China's One Belt One Road initiative.
Big order book but aggressive pricing for Chinese tech group.
Retail investors get the largest allocation of paper in Guotai Junan's flotation on the back of strong oversubscription ratios.
Another day another Chinese brokerage as Guolian Securities launches its Hong Kong flotation and offers a compelling valuation to stand out from a crowded field.
A throat lozenges manufacturer, a brokerage and a private obstetrics and gynaecology hospital group are all seeking to float shares in Hong Kong.
Citi's commercial bank in Asia-Pacific is capitalising on a growing desire among clients to tap bond, loan and equity markets.
We are pleased to announce the winners of our annual Country Awards for International Banks. Day One covers Bangladesh, China and Hong Kong.
The high level S&ED tries to keep US-China ties — arguably the most important bilateral relationship in the world — on a relatively even keel.